Dr. Colleen Cutcliffe, the CEO of Pendulum Therapeutics, recently introduced Gut Fuel, a product specifically designed to tackle three significant challenges: nourishing beneficial next-generation microbial strains, bridging the ongoing “fiber gap,” and providing a low-FODMAP option for individuals with digestive sensitivities, such as Irritable Bowel Syndrome (IBS). With a mere fraction of Americans meeting the recommended daily fiber intake, Gut Fuel aims to offer a convenient, food-based solution that can easily be incorporated into daily meals.
The product launch coincides with a growing public awareness of GLP-1 medications. While these drugs have gained considerable popularity, Cutcliffe highlighted the microbiome’s essential role in naturally supporting these pathways.
“Looking forward, the challenge with GLP-1s is that they can lead to significant gastrointestinal distress, particularly constipation, due to their effects on gastric emptying,” she explained. “We are thrilled to contribute to the solution by ensuring that we incorporate the right fibers and polyphenols. This isn’t your grandmother’s Metamucil—no more stirring endlessly only to leave half of it at the bottom of the glass. Our product features next-generation fibers and polyphenols that seamlessly fit into your daily routine.”
Cutcliffe also urged consumers to be cautious of misleading marketing claims related to alternatives for GLP-1 medications.
“Unfortunately, the market is flooded with products touting GLP-1 messaging, much of which is essentially garbage, misleading consumers,” she remarked. She stressed the necessity of credible sources and platforms dedicated to educating individuals with evidence-based information, helping them navigate the overwhelming options and make informed choices about their metabolic health.
Gut Fuel symbolizes Pendulum’s shift toward more comprehensive health regimens. Cutcliffe emphasized that it’s not solely about probiotics; the magic lies in the synergy of multiple ingredients working cohesively.
“To achieve optimal performance in a car, it’s not just about premium fuel; it’s also about having a high-performing engine,” she said. “If the microbiome serves as the engine, then the fuel represents the food you provide your body.”
Looking to the future, the company is also advancing research in women’s health through a partnership with Mayo Clinic, focusing on innovative microbial strains aimed at addressing menopause-related issues.
“At Pendulum, we are committed to creating products that I personally want to use,” she concluded.
